Insider Stock Trading History of Tananbaum James B


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Tananbaum James B since year 2005. The trader's CIK number is 1162061. At the time of this reporting, Tananbaum James B is the Director of Novavax Inc . (stock ticker symbol NVAX). See this page for all insider trading activities at Novavax Inc .

Note that in the past TANANBAUM JAMES B also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Tananbaum James B since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2008-07-31 NVAX Novavax Inc Buy 35,181 .00 0
2008-07-21 JAZZ Jazz Pharmaceuticals Inc Buy 190,334 .00 0
2007-06-14 CRTX Critical Therapeutics Inc Sale 195,751 2.29 448,661
2007-06-11 CRTX Critical Therapeutics Inc Sale 2,400 2.50 6,000
2007-06-12 CRTX Critical Therapeutics Inc Sale 60,910 2.38 144,843
2007-06-13 CRTX Critical Therapeutics Inc Sale 300,000 2.23 669,000
2007-06-07 CRTX Critical Therapeutics Inc Sale 1,000 2.68 2,680
2007-06-08 CRTX Critical Therapeutics Inc Sale 288,000 2.50 720,575
2007-06-06 CRTX Critical Therapeutics Inc Sale 330,794 2.69 889,174
2007-06-01 CRTX Critical Therapeutics Inc Sale 398,894 2.90 1,156,393
2007-06-04 CRTX Critical Therapeutics Inc Sale 315,773 2.76 871,533
2007-06-05 CRTX Critical Therapeutics Inc Sale 387,500 2.66 1,032,300
2006-12-11 VNDA Vanda Pharmaceuticals Inc. Sale 738,591 26.56 19,616,976
2006-12-12 VNDA Vanda Pharmaceuticals Inc. Sale 6,878 25.27 173,807

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tananbaum James B (Director of Novavax Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.